Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer

R. M. Elledge, Richard M. Elledge

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)82-83
Number of pages2
JournalBreast Diseases
Issue number1
StatePublished - 2005

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this